Journals / Tüberküloz ve Toraks / 1997 / Cilt: 45 - Sayı: 2

Ticlopidine induced fatal neutropenia and pneumonia

Ticlopidine'e bağlı fatal nötropeni ve pnömoni olgusu

Pages
140–143
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a conslusion, ticlopidine use İs supposed to be responsible for fatal neutropenia, thrombcytopenia and pneumonia observed in this patient, the risk-benefit ratio of this drug should be reconsidered.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:TICLOPIDINE INDUCED FATAL NETROPENIA AND PNEUMONIA Ticlopidine is a new antiaggregant used in prophylaxis of acute thromboembolic occlusions in cardiovascular system.
📊
Key Findings & Data:A 45 year old male using ticlopidine after coronary artery by-pass grafting surgery was hospitalized with a diagnosis of community-acquired pneumonia and given ampirical antibiotherapy till neutropenia had been documented, then the management was modified accordingly.
💡
Conclusion & Impact:As a conslusion, ticlopidine use İs supposed to be responsible for fatal neutropenia, thrombcytopenia and pneumonia observed in this patient, the risk-benefit ratio of this drug should be reconsidered.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

TICLOPIDINE INDUCED FATAL NETROPENIA AND PNEUMONIA Ticlopidine is a new antiaggregant used in prophylaxis of acute thromboembolic occlusions in cardiovascular system. Although its side effects are generally mild, it may cause potentially fatal outcomes. It's npt generally known that Ticlopidine was one of the reasons of drug-induced neutropenia. A 45 year old male using ticlopidine after coronary artery by-pass grafting surgery was hospitalized with a diagnosis of community-acquired pneumonia and given ampirical antibiotherapy till neutropenia had been documented, then the management was modified accordingly. Despite all these efforts, downhill progress could not be prevented and the patient died of neutropenic pneumonia and respiratory failure leading to multiorgan failure. As a conslusion, ticlopidine use İs supposed to be responsible for fatal neutropenia, thrombcytopenia and pneumonia observed in this patient, the risk-benefit ratio of this drug should be reconsidered.

Özet

Tlclopidine, kardiyovasküler sistemdeki akut tromboembolik tıkanmalarda koruyucu amaçla kullanılan yeni bir antiagregan ilaçtır. Yan etkileri genelde hafif düzeyde olsa da literatürde fatal sonuçlanabilen nötropeni olguları bildirilmiştir, ilaç yan etkisi olan nötropenide Ticlopidine'in nedenler arasında yer aldığı yaygın olarak bilinmemektedir. 45 yaşında, koroner arter by-pass operasyonundan sonra Tlclopidine kullanmaya başlamış olan bir erkek hasta, 40 gün sonra toplum kökenli pnömoni tablosuyla yatırıldı ve saptanan hötropeni-trombositopeni ile yaklaşım yeniden düzenlendi. Bütün tedavi ve destek sağlama girişimlerine karşın tablo ölümle sonuçlandı. Nötropeninin yol açtığı bu ağır enfeksiyon tablosundan sorumlu tuttuğumuz Ticlopidine'in profilaktik seçeneklerden birisi olarak fatal risk taşımasının önemine dikkatleri çekerek olgumuzu sunmayı uygun bulduk.

🔖

Cite This Article

TARHAN, O., ALTINIŞIK, G., YENİÇERİOĞLU, Y., UÇAN, E. S., KARGI, A., KURTOĞLU, B., BİBEROĞLU, K., KÜPELİOĞLU, A., ÜNDAR, B., AKPINAR, O., KARADAŞ, A. (2022). Ticlopidine induced fatal neutropenia and pneumonia. Tüberküloz ve Toraks, Cilt: 45 - Sayı: 2, 140–143. https://ajindex.com/articles/619608

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...